Cite
HARVARD Citation
Fei, X. et al. (2021). The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study. Clinical and translational medicine. 11 (10), p. n/a. [Online].